Rare diseases
Investigational molecules
Locations
Back to the Netherlands111 clinical trials in Enschede, The Netherlands across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on the Effectiveness and Safety of Mifepristone 50 mg Weekly for Contraception in Women
The NetherlandsThe NetherlandsStudy on Genotype-Guided Treatment with Carbasalate Calcium, Telmisartan, and Rivaroxaban for Patients with Peripheral Arterial Disease
The NetherlandsStudy of levamisole and prednisolone combination to prevent nephrotic syndrome relapse in children aged 2-16 years with first episode of steroid-sensitive disease
The NetherlandsStudy comparing carboplatin-cyclophosphamide versus paclitaxel with atezolizumab as first treatment for advanced triple negative breast cancer
The NetherlandsStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
The NetherlandsStudy of reduced pembrolizumab dosing compared to standard dose in patients with advanced non-small cell lung cancer
The NetherlandsStudy on Alpelisib and Fulvestrant for Advanced Breast Cancer in Patients with PIK3CA Mutation and Hormone-Receptor Positive, HER2 Negative Tumors
The NetherlandsStudy on Early Discontinuation of Nivolumab and Ipilimumab in Patients with Advanced Melanoma
The NetherlandsStudy on Personalized Ocrelizumab Dosing for Patients with Relapsing Remitting Multiple Sclerosis
The NetherlandsStudy on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids
The NetherlandsStudy of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on heart failure prevention and treatment of cardiovascular diseases. Studies include evaluation of new therapies for reducing cardiac events and managing arterial conditions.
Research includes novel drug combinations and preventive approaches for high-risk patients.
Comprehensive research in hematologic malignancies and solid tumors, with particular focus on innovative treatment combinations for acute myeloid leukemia and advanced cancers.
Trials evaluate targeted therapies and novel drug combinations to improve patient outcomes.
Studies addressing epileptic conditions and post-cardiac arrest neurological care, including innovative approaches to treating status epilepticus.
Focus on improving neurological outcomes in critical care settings.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
